Cuộc họp công bố kết quả kinh doanh Quý 2/2026 của Arrive AI (ARAI): Đẩy mạnh triển khai AP3 Plus và Danh mục dự án thương mại

Điểm tin chính

• Arrive AI đã báo cáo doanh thu quý 2/2026 đạt 14.700 USD, hầu như không thay đổi so với quý 1. Doanh thu tăng nhẹ so với cùng kỳ năm trước nếu không tính đến một dự án tư vấn bất thường trong quý 2/2025.
• Lỗ ròng theo báo cáo mở rộng lên 14,1 triệu USD so với 3,7 triệu USD của một năm trước đó, bao gồm 9,7 triệu USD chi phí phi tiền mặt liên quan đến việc chuyển đổi các kỳ phiếu đang lưu hành. Nếu không tính các chi phí này, lỗ ròng phi GAAP là 4,3 triệu USD.
• Tiền và các khoản đầu tư thanh khoản đạt tổng cộng 5,1 triệu USD vào ngày 30 tháng 6 năm 2026, so với 2,1 triệu USD tiền mặt vào ngày 31 tháng 12 năm 2025. Mức tiêu tốn tiền mặt hiện tại của công ty là khoảng 1,1 triệu USD mỗi tháng.
• Ban lãnh đạo dự kiến sẽ có hơn một tá điểm Arrive Point AP3 Plus trong kho và sẵn sàng giao hàng vào giữa tháng 9. Mục tiêu ra mắt dòng AP4 thế hệ tiếp theo vẫn là quý 1/2027.
• Hoạt động thương mại tập trung vào lĩnh vực y tế, sản xuất dược phẩm và giao hàng dược phẩm chuyên khoa. Tuy nhiên, một số cơ hội vẫn đang ở giai đoạn thư ngỏ ý định, thảo luận thử nghiệm hoặc đàm phán ban đầu.
• Arrive AI đã bổ nhiệm Piyush Phadke làm Giám đốc Tài chính (CFO), có hiệu lực từ ngày 17 tháng 8. Ban lãnh đạo đã nhấn mạnh kinh nghiệm của ông trong lĩnh vực thị trường vốn và tài chính công ty đại chúng trong bối cảnh công ty đang đánh giá các phương án huy động vốn.

Dữ liệu tài chính cốt lõi

Kết quả kinh doanh và hoạt động

Arrive AI đang chuyển từ các đợt triển khai hạn chế sang xây dựng lượng hàng tồn kho ban đầu. Hơn một tá thiết bị AP3 Plus dự kiến sẽ có sẵn vào giữa tháng 9. Sản phẩm này bao gồm một hệ điều hành mới và phần mềm cho phép khách hàng giám sát các điểm Arrive Point cũng như mạng lưới rộng lớn hơn của họ.

Y tế vẫn là lĩnh vực triển khai lâu đời nhất của công ty. Bệnh viện Hancock Regional đã bổ sung thêm một điểm Arrive Point trong quý, cho phép di chuyển giữa các tòa nhà. Ban lãnh đạo kỳ vọng đợt mở rộng này sẽ tạo ra doanh thu tăng thêm trong quý 3 và quý 4/2026, nhưng không nêu rõ con số cụ thể.

Arrive AI cũng hợp tác với Nexus AMR, đơn vị sẽ đưa các sản phẩm của công ty vào danh mục tự động hóa của mình và giới thiệu công nghệ này tại Trung tâm Đổi mới TECNEXUS. Ban lãnh đạo cho biết mối quan hệ hợp tác này đang tạo ra thêm các khách hàng tiềm năng trong số các khách hàng thuộc lĩnh vực bệnh viện, y tế và dược phẩm.

Trong lĩnh vực sản xuất, Arrive AI đang hợp tác với DXC để đưa công nghệ của mình vào các cơ sở sản xuất dược phẩm lớn. Ban lãnh đạo cho biết năng lực tích hợp hệ thống của DXC có thể giúp công ty kết nối hiệu quả hơn với các khách hàng doanh nghiệp lớn.

Công ty đã ký thư ngỏ ý định với LifeSpan Pharmacy và CarDon để nghiên cứu chương trình giao hàng dược phẩm bằng máy bay không người lái tự hành. Công ty cũng đang tiến hành thảo luận giai đoạn đầu với một số công ty thuộc danh sách Fortune 500 về các cơ hội giao hàng dược phẩm tiềm năng.

Arrive AI cũng đang thảo luận ở giai đoạn đầu với Avride về các chương trình thử nghiệm tiềm năng sử dụng Arrive Point cho dịch vụ giao hàng không cần người nhận. Avride dự kiến sẽ hoạt động trên hơn 20 khuôn viên cơ sở tại Mỹ vào cuối năm, nhưng ban lãnh đạo làm rõ rằng các cơ sở này không đại diện cho các cam kết triển khai Arrive Point.

Công ty báo cáo đã được cấp 10 bằng sáng chế tại Mỹ và có 4 đơn đăng ký đang chờ xử lý tại Mỹ. Công ty cũng có 13 bằng sáng chế quốc tế đã được cấp, chủ yếu ở Châu Á, và gần đây đã nhận được phê duyệt cho bằng sáng chế đầu tiên tại Liên minh Châu Âu. Ban lãnh đạo cho biết họ đang đánh giá các cơ hội cấp phép quốc tế.

Định hướng của Ban lãnh đạo

Ban lãnh đạo dự kiến hơn một tá thiết bị AP3 Plus sẽ có sẵn trong kho và sẵn sàng giao hàng vào giữa tháng 9 năm 2026.

Mục tiêu ra mắt AP4 là quý 1/2027. Thiết bị này đang được thiết kế để hỗ trợ nhiều đợt giao hàng, việc lấy và trả hàng đồng thời bằng robot di động tự hành, cũng như giao hàng bằng máy bay không người lái. Chuỗi cung ứng của dòng sản phẩm này dự kiến sẽ mở rộng lên hàng trăm thiết bị trong năm 2027, mặc dù ban lãnh đạo cảnh báo rằng việc triển khai thực tế ở quy mô đó vẫn chưa chắc chắn.

Arrive AI cũng kỳ vọng sẽ có các mẫu thử nghiệm APX, hay còn gọi là AP5, vào cuối năm 2027. Chuỗi cung ứng liên quan đang được thiết kế để hướng tới sản xuất hàng nghìn hoặc hàng chục nghìn sản phẩm, nhưng đây vẫn là mục tiêu phát triển dài hạn chứ chưa phải cam kết triển khai.

Rủi ro và các yếu tố cần theo dõi

• Doanh thu vẫn còn hạn chế so với các khoản lỗ được báo cáo của công ty và mức tiêu tốn tiền mặt hàng tháng khoảng 1,1 triệu USD.
• Nguồn vốn trong tương lai có thể bao gồm chương trình ATM của công ty, bản đăng ký S-3 hoặc hạn mức tài trợ vốn cổ phần còn lại. Ban lãnh đạo cho biết công ty có các phương án tài trợ vốn và đang quản lý chúng với sự tập trung vào bảng cân đối kế toán và lợi ích lâu dài của cổ đông.
• Một số cơ hội thương mại vẫn đang dừng lại ở các cuộc thảo luận giai đoạn đầu hoặc mới chỉ được điều chỉnh bằng thư ngỏ ý định. Ban lãnh đạo cho biết họ sẽ chỉ xem các thỏa thuận là chính thức sau khi chúng được ký kết.
• Chuỗi cung ứng đang được thiết kế cho quy mô sản xuất cao hơn đáng kể, nhưng ban lãnh đạo thừa nhận rằng việc triển khai hàng trăm thiết bị AP4 trong năm 2027 là chưa thể đảm bảo chắc chắn.
• Các câu hỏi của nhà đầu tư đã nêu lên mối lo ngại về giá cổ phiếu, việc tuân thủ quy định của Nasdaq, khả năng bị hủy niêm yết và tính thanh khoản. Ban lãnh đạo đã phản hồi bằng cách nhấn mạnh vào các nhu cầu tìm hiểu thương mại, phát triển sản phẩm và tính linh hoạt trong huy động vốn.

Nội dung nổi bật từ phiên Hỏi & Đáp với nhà phân tích

Khi được hỏi về lộ trình tăng từ hàng tá điểm Arrive Point lên hàng trăm hoặc hàng nghìn điểm, ban lãnh đạo cho biết việc mở rộng quy mô phụ thuộc vào sự phát triển phối hợp giữa sản phẩm và chuỗi cung ứng. AP3 Plus đại diện cho đợt triển khai đầu tiên của nền tảng mới, AP4 được thiết kế cho chuỗi cung ứng có khả năng hỗ trợ hàng trăm thiết bị, và APX/AP5 được định hướng cho quy mô lớn hơn đáng kể.

Ban lãnh đạo làm rõ rằng sự hiện diện dự kiến của Avride tại hơn 20 cơ sở không đồng nghĩa với 20 đơn đặt hàng Arrive Point bổ sung. Các công ty hiện đang thảo luận về các chương trình thử nghiệm tiềm năng.

Về chuyển đổi thương mại, ban lãnh đạo cho biết một nhóm đáng kể các cuộc thảo luận với đối tác đã tiến tới các vòng đàm phán thứ hai và thứ ba. Công ty đang ưu tiên các đợt triển khai mang lại sự phù hợp chiến lược tốt nhất trong 12 tháng tới.

Về mặt tiếp thị, Arrive AI mô tả chiến lược của mình là phương pháp tiếp cận doanh nghiệp có mục tiêu thay vì quảng cáo diện rộng đến người tiêu dùng. Trọng tâm là các tổ chức có thể hưởng lợi từ chuỗi cung ứng giám sát an toàn, giao hàng không cần người nhận và tích hợp trên các đội máy bay không người lái và robot.

Toàn văn biên bản cuộc họp báo cáo kết quả kinh doanh

Toàn văn cuộc gọi công bố kết quả kinh doanh

Phần trình bày của ban lãnh đạo

Operator

Good morning, everyone, and thank you for joining us today. On the call is Dan O'Toole, Arrive AI's Chairman, CEO, and Founder, along with Ian Geise, our Head of Commercialization, who's joining us for the first time today. The rest of Arrive AI's leadership team is also here to answer questions later in the call. The earnings press release issued this morning is available in the Investor Relations section of the company's website at arriveai.com.

Before we begin, please note that today's remarks may include forward-looking statements regarding future financial results, operations, and performance. These statements are not guarantees of future results and are subject to risk and uncertainties that could cause actual outcomes to differ materially. We encourage investors to review the Risk Factors section detailed in Arrive AI's SEC filings, which are also available on the company's website.

Now, I will turn the call over to Arrive AI's CEO, Dan O'Toole.

Daniel O’Toole

Thank you. Hey everyone, Dan O'Toole here. Thank you for joining us today. We're going to keep our prepared comments concise, so let's get right to it. But I also want to say, why don't you ever see elephants hiding in trees? Because they've gotten really good at it. But I really want to say the elephant in the room has arrived with AI. We're seeing a huge uptick in big players wanting to explore deploying our technology, and that is what is really exciting. So let's get this going.

To start this morning, I'd like to welcome Piyush Phadke as Arrive AI's new CFO, Chief Financial Officer, effective August 17th. As detailed in this morning's press release, Piyush brings more than two decades of Wall Street experience, including senior capital markets roles at Bank of America, BTIG, and Jefferies before moving into public company CFO leadership. That combination gives him a rare vantage point. He sat on the banking side, structuring financing for growth companies, and he sat in the CFO seat, managing the balance sheet and investor relationships that come with public company life.

What stood out to me most is how aligned Piyush is with our vision for Arrive AI. He understands the scale of the opportunity in front of us in autonomous logistics. And he's just as focused as we are on translating this quarter's commercial traction into long-term shareholder value, which I will elaborate on shortly. We'll hear directly from him on future calls and in the investor conversations as we move forward. I also want to thank Todd Pepmeier for his contributions while here at Arrive AI.

Now let's get into what's driving the business forward, including real commercial traction, continued technology progress and a clear opportunity ahead for Arrive AI. The prepared remarks you're about to hear will be delivered using AI-generated versions of both mine and our Head of Commercialization's voice, Ian Geise. That's the same format that we've used in the past. For us, this reflects how we think about artificial intelligence as a practical tool that can improve efficiency, scalability, and communication, the same philosophy that drives our platform and autonomous logistics network.

After the prepared remarks conclude, we'll return to a live question-and-answer session on questions that were submitted ahead of this call. So with that said, let's begin the prepared remarks.

Thanks, everyone. This quarter, we want to spend less time talking about where we're headed in the abstract and more time talking about the deals and partnerships and the progression we have made over the past several months. We expect to have more than a dozen AP3 Plus Arrive Points in stock and ready to ship by mid-September, representing our first wave of expanded availability and the solidification of our supply chain. Looking ahead, we're already developing the AP4, which is targeted for the first quarter of 2027 and will build on what AP3 Plus brings to the network. This is ideal timing to take advantage of the commercial traction we are seeing in the second half of the year.

To walk through that in detail, I've asked Ian Geise, our Head of Commercialization, to join us today for the first time. Ian leads our commercial pipeline, and he's going to provide you with an inside look at where things stand.

Ian Geise

Thanks, Dan. It's easiest to think about our pipeline across three industries where we're seeing the strongest traction right now: healthcare, manufacturing and specialty pharmacy delivery. In healthcare, Nexus AMR is pleased to partner with us to deliver end-to-end autonomous solutions for customers across multiple industries. The integration of Arrive AI's products into their automation portfolio enhances productivity and expands the value they deliver to healthcare organizations and other businesses facing persistent and growing labor challenges. Customers from around the world regularly visit the TECNEXUS Innovation Center, where they showcase best-in-class autonomous mobile robots and emerging technologies. Nexus is proud to feature Arrive AI's innovative solutions and has welcomed us as a key strategic partner.

Hancock Regional Hospital remains our anchor healthcare deployment. And this quarter, Hancock expanded their network by adding an additional Arrive Point, enabling building-to-building movement. This is a significant milestone since demand for building-to-building movement and secure exchange will be paramount in healthcare and in large campus facilities.

In manufacturing, we've partnered with DXC to bring our technology into large pharmaceutical manufacturing environments, facilities with a global footprint, each spanning 500,000 square feet or more where moving product across the campus, including by drone for longer distances, is a real operational need. DXC's systems integration expertise also helps us plug into large enterprise customers faster than we could on our own.

We've also announced a letter of intent with LifeSpan Pharmacy and CarDon to explore an autonomous drone pharmacy delivery program. We are also engaged in early-stage discussions with several Fortune 500 companies regarding potential pharmaceutical delivery opportunities.

We're also seeing broader momentum with our autonomous delivery partners. Avride, which builds autonomous delivery robots backed by one of the industry's longest-running autonomous driving programs, became the continuity partner for universities when Starship Technologies exited U.S. campus operations. By the end of this year, Avride expects to be operating on more than 20 campuses nationwide, working with Grubhub, Uber Eats and major food service operators.

What's next for Avride is more campuses, expanded city deployments, faster and more reliable service, and most importantly, where we fit in, creating partnerships across the ordering and logistics stack so last-mile delivery becomes truly autonomous, end to end. This mutual goal will be key as we identify potential partners. As of today, we have a growing number of commercialization conversations underway, and a meaningful subset of those have already progressed into second- and third-round discussions. These later-stage conversations are with partners we believe are the most likely to move forward into formal agreements.

We're introducing this framing to give you a clearer view into the momentum we're seeing and our traction with potential partners. At the same time, we'll continue to only treat agreements as firm once they're signed, and we'll announce each finalized partnership individually as it's secured. We expect to keep building on this across healthcare, manufacturing and specialty delivery in the coming quarters.

Daniel O’Toole

Thanks, Ian. On the financial side, given the very recent CFO transition, I will walk through the highlights for the second quarter results. Second quarter revenue was in line with Q1 at $14,700 for the quarter. Our recently announced expansion with Hancock is expected to produce incremental revenue in the third and fourth quarters this year.

Excluding revenue from a non-recurring consulting project in the year-ago quarter, revenue was up slightly year over year. Net loss for the second quarter was $14.1 million compared to the $3.7 million net loss in the second quarter of 2025. However, the reported net loss includes $9.7 million in non-cash expenses related to the conversion of our outstanding notes. Excluding these non-cash expenses on a non-GAAP basis, net loss for the second quarter was $4.3 million. Cash and liquid investments on hand were $5.1 million at June 30th, an increase from $2.1 million in cash at December 31st. Our current cash burn rate is approximately $1.1 million per month.

During the quarter, we completed the filing of an S-3 registration statement for up to $100 million. We also finalized the terms of our at-the-market offering, or ATM offering, up to a maximum capacity of approximately $15 million. The amount and timing of sales under that agreement will be disclosed quarterly as required. In addition, we retain the available capacity of $19 million in future prepaid advances under our previous 2025 equity line facility.

I also want to speak directly to something I know is on a lot of people's minds, our ability to keep funding this business going forward. We continue to have real optionality in front of us right now on financing, and Piyush's capital markets background is already helping us sharpen how we think about those paths. Our current cash burn reflects deliberate investment in the team, technology, and infrastructure required to convert our commercial pipeline into scaled revenue. And we're being careful about which financing and operating decisions we make and when to do what's right for shareholders over the long term. At the same time, we are prudently managing operating and investment spend to drive growth while maintaining a disciplined focus on the balance sheet.

I want to be direct about this. We are not in a position where we're at risk of running out of funds. We have options, and with Piyush's experience structuring financing for growth companies, we're working through them strategically and with real discipline.

To wrap up, this quarter is about proof: real partnerships, real deployments and real momentum in our pipeline across healthcare, manufacturing and specialty delivery. We appreciate your continued support and engagement.

With that, Ian and I will now return live for Q&A, along with the rest of our team.

Operator

[Operator Instructions] And our first question comes from Jack Codera with Maxim Group.

Phần hỏi đáp

Jack Codera

You guys highlighted a couple of partnerships. And then you mentioned there, about a dozen Arrive Points kind of targeted to be ready to ship this, I think you said by the end of this year. I'm wondering how many Arrive Points do you have out there operating right now? And kind of how does that connect to, like for example, this like 20 campuses you're taking over? Is that like an incremental 20 Arrive Points? How should we be thinking about that?

Daniel O’Toole

Yes, hey, real quick. Thanks for being on the call here, Jack. Dan O'Toole, CEO. I just want to say that the over a dozen units that we mentioned in the earnings call represents a huge multiplier of our past deployments. So while over a dozen isn't a huge number in the abstract, it really marks on our traction that we're seeing, and it's a huge multiplier on what we've had deployed so far. So I think the trajectory is really vertical for where we're going and what we're doing. I'm going to let Ian Geise, our Head of Commercialization, take the last part of that question. Go ahead, Ian.

Ian Geise

Yes, just to clarify the statement on campuses, the news that was iterated in that statement had to do with Avride's takeover of Starship's departure from campuses to do on-campus delivery. We are in early conversations with Avride right now of employing the Arrive Point network into potential pilot programs in which we could increase efficiencies for unattended delivery.

Jack Codera

Okay, yes, that's perfect clarification. And it's exciting to see that you're getting a multiplier on kind of what was existing out there. I guess, kind of the big question is, how should we think about -- what are the big sticking points that you're kind of seeing that will enable you to start talking about Arrive Points in -- kind of like hundreds of Arrive Points or thousands of Arrive Points? Do you think it's -- is it more about adoption? Do you need more manufacturing scope? I'd just like to get your thoughts like on the main sticking points.

Daniel O’Toole

Thanks, Jack. We appreciate the thoughtful questions and the opportunity to share these answers that I'm sure a lot of people are thinking about. I'm going to ask Mark Hamm, our COO, to take that one. Mark?

Mark Hamm

Yes, thanks, Jack, for the question. In Q1, we consolidated our roadmap, our product plan, our supply chain and the delivery of the 12 units in September. That's the first installment on new units -- it's called AP3 Plus -- that have our new operating system and our new software that enables operators and customers to see everything that's going on with their Arrive Points and their network.

Then what comes in Q1 is AP4, which is the first product that will support multiple deliveries at once, AMR pickup and drop off at the same time, drone delivery. And that supply chain has been designed to scale to hundreds over the course of 2027. It remains to be seen if we deploy that many, but that's what we're looking at supply chain-wise.

And then the following year, we would have prototypes at the end of next year for APX, the future generation, or AP5, you may hear it called, which is designed for even greater capacity and more automated handoffs in more situations. And that supply chain is being designed for thousands, tens of thousands. So it's a progression, a ramp. And kind of in parallel, once the supply chains are in place for that, then go-to-market follows that and provides the opportunities.

Operator

Thank you. I would now like to turn the call back over to Arrive AI for questions.

Daniel O’Toole

Yes, real quick. All right. This is Dan. I'm going to take this opportunity to introduce Piyush Phadke, our new CFO. Piyush, thanks for joining the call and thanks for joining the company. I'm really excited.

I just -- I want to give a quick shout-out, I guess, to Adele with Alliance Advisors, our trusted partner, our investor relations firm. They knew we were looking to get a really like-minded, educated or streetwise, I guess you could say, CFO. Somebody that -- my personal wish list was somebody that was entrepreneurial, somebody that could navigate the capital markets, could narrate an earnings report to analysts and investors and be M&A-minded. And I think we've got exactly what we're looking for. Piyush, if you're there, I'd like to say hey to you and have you give a little bit of a background on yourself to our investors.

Piyush Phadke

Sure. Thank you. Thank you, Dan. And thank you to the team and to investors who have joined this call. So I'm Piyush Phadke, I'm the new CFO of Arrive AI. I am very excited to be here. I really believe in the mission and believe we are the future of autonomous deliveries.

You know, for me, joining was all about fit. I came to the office near Indianapolis last week and spent time, spent three days there with everyone, up from Dan to all the C-suite, the developers, engineers. And the thing that I noticed was just really the energy that, you know, that flows from Dan. But really, everyone was just so excited to be there and to be able to be building something that's going to be big.

And I was able to see kind of a demo of an Arrive Point, and I had never seen it before other than kind of on the website. And it was really interesting to kind of see that live and see how the different technology works. So I'm really excited for the opportunity, and I'm looking forward to doing a lot of great things with Dan and team.

Daniel O’Toole

Thanks so much, man. We're looking forward to really leveraging your relationships and getting our sleeves rolled up and getting us to the next level. So really excited that you're on our team, man. I can't wait to hit the ground running here.

I want to turn this over to Tasha Jones, our Head of Marketing. And she's going to tee us some questions up there. Tasha?

Tasha Jones

Yes. The first question we have here, we received several questions about the stock price and the NASDAQ compliance, including concerns about a potential delisting or liquidity issues. This comes from Leon, Jake, Robert and [ Brenski ].

Daniel O’Toole

I'm going to -- the way we're going to format this, I'm going to assign questions so we're not tripping over each other. I'll assign answers. I'm going to take this one myself. Dan O'Toole, CEO.

Obviously, the big thing every day is share price traction, delisting and all these kind of things. Yes, I can tell you this. We went public over a year ago, 5,000 pre-public investors on our cap table. We have everyone shoulder to shoulder with us when we think about share price, market traction, having a great product. There's a whole formula of specifics that come together that equal your share price, your market cap and how you're viewing the market.

And I can tell you, when we went public a year ago, it was never in the plan to be profitable day one. It was never in the plan to be revenue neutral day one. What wasn't the plan was to lose money. And that wasn't because we wanted to lose money. It's just the reality. When you're running in a race, you don't start at the fastest speed, you start from a standing stop and you get faster and faster.

Well, I can tell you, we are getting faster and faster. The amount of inbound inquiries that are coming into our company are bigger than we've ever seen. In the last 30 days, we've had more inquiries than we've had in the history of the company put together. The market is taking note of what we're doing and then realizing that autonomous delivery and pickup of all sorts will not happen without an Arrive Point in that ecosystem.

We unlock autonomy. We're creating a frictionless environment between drones, robots, APs and people, and that is what the market needs. Scalability, when you're dropping things on the ground or picking them up from the ground, is a non-starter. When you add unattended delivery from Arrive AI, it all changes.

And when you guys invest into this company, you invest in our IP. Our IP starts where autonomous delivery and pickup starts. So if you have a locker or a mailbox, that's fine. That's public domain, that's old. When you have this new element of autonomous delivery and pickup where everything is going, that is Arrive AI. We are building that infrastructure. We own the doorstep to every public business throughout the world. So that's where you're investing in. Tash, I'm going to hand it to you.

Tasha Jones

Yes, so we also received a couple of questions asking us to describe our growth plan for the remainder of this year and next, including how we plan to scale revenue and secure purchase orders, letters of intent and strategic partner agreements. This was Raul and Albert's question.

Daniel O’Toole

I'm going to hand it over to Ian. Ian is our Head of Commercialization. Go ahead, Ian.

Ian Geise

Thank you for the question. I think we addressed most of that in my prepared statement, but I'll go ahead and answer it, especially off the great words that Dan just stated. And that is the amount of awareness that is now for the inefficiencies of drop-off, pickup throughout all of the different companies that have been launched, whether it's drone companies or robotics companies, there's more and more awareness for what is lacking, and that is indeed the Arrive Point of being able to do the handoff and the pickup.

Nexus saw this clearly, and we created that partnership with Nexus and we're getting more and more leads that are coming in the pipeline for hospital systems, medical, pharmaceutical, and they keep growing exponentially. So we anticipate very big things from all of these different elements of our pipeline. And as Mark stated in terms of the product deployments, we are being very careful with how we are allocating that product and getting the best fit for the next 12 months and forward.

Daniel O’Toole

Tash?

Tasha Jones

Okay. So, this next one comes from Ryan, who's been with us since the DroneDek days. What do you feel has been the biggest challenge with running a new publicly traded company in front of such a broad audience with the ability to say whatever they want, whenever they want? And what's been the biggest advantage?

Daniel O’Toole

You know, I would say no challenge, Ryan, just opportunity. Thanks for asking, and thanks for being with us since the beginning. Now I don't forget the OG guys, Brian Grigsby, [ Jeff Kong ], others. Appreciate everybody that's out there listening today. We know that you care.

You know, just opportunity. No two days are the same, every day is an exciting new day. You come in, and then Piyush mentioned the energy in the office. Every day I come in here, it's palpable. You can see high morale. You can see a dizzying evolution of projects. People are prideful. Everyone's trying to outmaneuver the next guy with great ideas and pride and be able to show off. You know, we have a normal showcase of sharing what's happening here, and we all rally and share that every day.

I'd be a hypocrite if I said anything was a negative. While there's things that aren't great sometimes, you gotta take the bad with the good. This is everything that I signed up for. It's better than I could have ever imagined.

I know our share price is down, and I'm not diminishing that. But what I'm saying is, I've come up with a mantra, what goes down must go up. It's anti-gravity, and that's what we're doing here at Arrive AI. I welcome questions not just on these earnings calls, but everybody knows how to reach me, and I want to be there for you guys. So thank you for that question, Ryan.

Tasha Jones

Okay. And this next one is -- we received a question about brand awareness, specifically how we're approaching marketing, given that many investors say they don't hear Arrive AI's name come up in their industries.

Daniel O’Toole

Mark, you want to take that one?

Mark Hamm

Yes. So just as we go through phases on developing our product and our supply chain, there are natural phases to how we develop our capabilities to go to market, and along with that, our brand. While it took a lot of attention and evangelizing the future of drone and robotic delivery to get here and to get funded and to put these resources and team in place, I think everybody's well aware of all the efforts, from Walmart and Zipline and just everybody out there, DoorDash. So that's no longer in question.

What we're focused on now is kind of that rifle shot approach to enterprise accounts and partners that are really the early innovators, the strategic investors in infrastructure like ours and what does it mean to market to them account by account. So you probably don't run into a lot of advertising for GE or Rolls-Royce aircraft engines in your life because you're not the purchaser of those things. We're looking for those equivalents in our industry that need to understand the awareness, the trade-offs, the chain of custody advantages, the efficiency advantages that our network brings to their fleets and their communities and their campuses, and that's where our marketing is focused and our branding is focused on.

Daniel O’Toole

Thank you. Tash?

Tasha Jones

Yes. Finally, you guys have had some strong patent news internationally. What's next? Are you guys looking at Asia? This one is from Rohan.

Daniel O’Toole

I'll tee that over at John Ritchison, our Chief Legal Counsel and our patent attorney. John?

John Ritchison

Thanks, Dan. That's a great question. I appreciate that question from the standpoint, gives me a lead -- I'll lead into it to talk a little bit about our IP. I'm going to break it up into two parts.

First, let me speak to the U.S. IP. We currently have 10 approved patents or issued patents. We've got 4 more pending in the patent office. And with that, we believe we've got covered the initial IP that we need for a strong moat to keep us in a competitive position.

I think Piyush mentioned about the energy that he saw when he was there. I'd say it's more than energy. There's a lot of strength in our young engineers, the men and women that are out there have come up with a lot of great ideas. I don't know of any other -- I'm sure they're out there, but I don't know of any other company right off the top that's got their IP attorney right on-site with their engineers. That's one thing that we do, and we try to strongly take those ideas. Currently, we've got about 19 ideas that are in the hopper. Those are coming through at the rate as the engineers finish up their design and development. But again, that's the U.S.

Now let me turn to the second part, and that's the international. We haven't talked much about the international, but we've been very strong in getting our patents across the pond and working out there. The specific question was Asia. We've got -- to date, we've got 13 issued patents. Most of those are in Asia, with the exception, I think, of South African and Brazil patents. The rest of them are in Asia proper, India, Singapore, Australia, Japan. I could list them, but that takes too much time. That's exciting from a standpoint that Asia is an immediate place that we have decided to start working hard on, trying to look at how we can take these international patents and doing some licensing with local concerns.

The other part of international we don't talk about much -- and I don't want to get too technical, but that's Europe. Most of the people in this room know it, but I'm sure the people on the call don't. We just recently got approved with our first patent for the European Union. That opens up the entire European for us to go ahead and open up those additional countries. So along with the Asian efforts, we now have the strong results, and we'll start heading up into Europe with our international licensing opportunities. I'll turn it back to Dan.

Daniel O’Toole

John, another quick question. You would agree that we have a strong first position patent portfolio in this space, right?

John Ritchison

Yes. I don't have it memorized like Dan does, but we beat several strong companies, Amazon, UPS, FedEx, a few others. And with that, when I say beat, our patents got out and approved by the patent office before theirs did. So that put us in a first position.

But I'd also be less than honest with you if I didn't say that a first position is nice, but our first position also comes with a strong number of claims. So we've got a lot of components and features in there. I thought that they were pretty well complete. And then I met these 40 engineers that we've got on-site that are thinking totally out of the box, so we've got a lot more stuff coming down the pipe.

Daniel O’Toole

And one more patent that people don't think about us for, if you could just throw something up about this, our winch patent for a [ drone package ].

John Ritchison

Yes, we've got -- that was one of the things with our strategic purchase, we rolled in what we call around here, a winch patent, which is a different way to handle the product coming from the drones. It's unique, and it allows you to focus or drop that package in a much more organized and controlled method.

Daniel O’Toole

Yes, thanks a lot. Hey, I just want to say, appreciate everybody listening to the call, caring enough to want to know what we're up to from a bird's eye view here at Arrive AI. I just want to say that the trajectory is strong. We are on track with every deliverable that we mark and take note of, and we are right on pace with every aspect of this business. We're running on all cylinders. Things are amazing in regard of getting recognized in the marketplace.

And I want to thank everybody for joining the call today. Also, I want to give a shout-out to my son, Bryce O'Toole. He's listening from his investment banking internship in New York City right now. Go get them, Bryce. Thanks, everybody. Back to our operator.

Operator

Thank you. This concludes the conference. Thank you for your participation. You may now disconnect.